TrialLung2025

Efficacy and Safety of Fexuprazan Versus Esomeprazole for Gastroesophageal Reflux Disease-Related Chronic Cough: A Randomized, Double-Blind, Active-Controlled Exploratory Trial.

Noeul Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.